![]() |
|
|||
|---|---|---|---|---|
|
|
||||
|
BNY CONVERGEX GROUP INTEGRATES EZE OMS INTO DERIVATEX
Posted March 7, 2008
NEW YORK – Global agency brokerage and investment technology solutions
provider BNY ConvergEx Group LLC has integrated its DerivatEx options
execution platform into the Eze Order Management System (OMS), a
multi-asset class system from Eze Castle Software LLC, a BNY ConvergEx
company that provides buy-side firms with execution integration for
various asset classes to optimize the investment workflow.
“We continue to leverage the capabilities within ConvergEx to expand our
Eze OMS offering and provide our clients a variety of choices for
execution,” says Tom Gavin, Chief Executive Officer, Eze Castle
Software. “This integration gives our clients the flexibility to easily
execute options orders through the innovative DerivatEx platform.”
The integration enables Eze OMS users to send option orders directly
into DerivatEx and receive execution reports back through the Eze OMS
blotter. In addition, Eze OMS users will now be able to access the
recently released ConvergEx suite of options algorithms, designed to
help clients limit their market impact and find liquidity across all
options exchanges. DerivatEx is powered by LiquidPoint LLC, a listed
options execution and trading technology company that is also part of
BNY ConvergEx.
“We are constantly seeking ways to keep ConvergEx customers ahead of the curve,” says Anthony J. Saliba, Chief Executive Officer of LiquidPoint. “With this integration, Eze OMS customers now have seamless access to both the DerivatEx low latency options execution platform and our advanced execution algorithms. The ‘natural fit’ of the Eze and LiquidPoint offerings brings the client the best integrated solution.”
|
||||
Questions or comments? Get in touch with us at info@globalinv.com
© 2005-2008 Investment Media Inc.